Bristol-Myers Squibb (BMY) Interest Coverage Ratio: History & Chart

Bristol-Myers Squibb Company(BMY)

Drug Manufacturers - General · Princeton, NJ

$64.48-0.21 (-0.32%)

Delayed quote: Sep 9, 2026, 3:05 PM EDT

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism. The portfolio also features Opdivo, utilized across various anti-cancer indications; Pomalyst/Imnovid, prescribed for multiple myeloma patients; and Orencia, targeting active rheumatoid arthritis and psoriatic arthritis in adults. Other key therapies are Sprycel, employed in the management of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, indicated for patients with unresectable or metastatic melanoma; and Abraxane, a protein-bound chemotherapy formulation. Furthermore, Bristol-Myers Squibb offers Reblozyl, addressing anemia in adult patients with beta thalassemia; Empliciti, another treatment option for multiple myeloma; and Zeposia, designed to treat relapsing forms of multiple sclerosis. Revolutionary treatments like Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for adult patients battling relapsed or refractory large B-cell lymphoma, are also part of its lineup. Completing its product range are Inrebic, an oral kinase inhibitor specifically for adult myelofibrosis, and Onureg, used in the treatment of adult patients with acute myeloid leukemia (AML). Bristol-Myers Squibb distributes its pharmaceutical products through a diverse network encompassing wholesalers, distributors, pharmacies, retail outlets, hospitals, clinics, and governmental organizations. Founded in 1887 and formerly known as Bristol-Myers Company, the firm maintains its headquarters in New York, New York.

Princeton, NJ

32,500 employees

www.bms.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Christopher Boerner

View full financials

BMY Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

7.26x

INTEREST COVERAGE RATIO AVG TTM

8.02x

INTEREST COVERAGE RATIO AVG 3Y

6.61x

INTEREST COVERAGE RATIO AVG 5Y

6.74x

INTEREST COVERAGE RATIO AVG 10Y

12.95x

INTEREST COVERAGE RATIO AVG 15Y

14.29x

INTEREST COVERAGE RATIO AVG 20Y

17.44x

CURRENT VS TTM AVG

-9.48%

CURRENT VS 3Y AVG

+9.79%

CURRENT VS 5Y AVG

+7.67%

CURRENT VS 10Y AVG

-43.94%

CURRENT VS 15Y AVG

-49.20%

CURRENT VS 20Y AVG

-58.38%

SECTOR MEDIAN · HEALTHCARE

6.88x

median of 82 covered companies

CURRENT VS SECTOR MEDIAN

+5.45%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Bristol-Myers Squibb Company (BMY)	$131.71B	7.26x	8.02x	6.61x	6.74x
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$132.26B	357.95x	357.95x	174.48x	123.56x
Intuitive Surgical, Inc. (ISRG)vs ›	$124.42B	N/A	55.58x	55.58x	55.58x
CVS Health Corp. (CVS)vs ›	$122.16B	3.33x	3.10x	3.72x	4.16x
Danaher Corporation (DHR)vs ›	$143.84B	19.38x	19.02x	23.18x	23.65x
Medtronic plc (MDT)vs ›	$118.00B	9.04x	8.61x	8.24x	8.04x
Stryker Corporation (SYK)vs ›	$106.10B	8.05x	10.41x	10.98x	10.79x
McKesson Corporation (MCK)vs ›	$104.83B	26.13x	21.60x	19.33x	18.13x
Pfizer Inc. (PFE)vs ›	$158.93B	5.78x	5.55x	10.96x	11.04x
Sanofi (SNY)vs ›	$103.08B	15.33x	13.49x	16.74x	20.21x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Bristol-Myers Squibb Company (BMY)

$131.71B

7.26x

8.02x

6.61x

6.74x

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$132.26B

357.95x

174.48x

123.56x

Intuitive Surgical, Inc. (ISRG)vs ›

$124.42B

N/A

55.58x

CVS Health Corp. (CVS)vs ›

$122.16B

3.33x

3.10x

3.72x

4.16x

Danaher Corporation (DHR)vs ›

$143.84B

19.38x

19.02x

23.18x

23.65x

Medtronic plc (MDT)vs ›

$118.00B

9.04x

8.61x

8.24x

8.04x

Stryker Corporation (SYK)vs ›

$106.10B

8.05x

10.41x

10.98x

10.79x

McKesson Corporation (MCK)vs ›

$104.83B

26.13x

21.60x

19.33x

18.13x

Pfizer Inc. (PFE)vs ›

$158.93B

5.78x

5.55x

10.96x

11.04x

Sanofi (SNY)vs ›

$103.08B

15.33x

13.49x

16.74x

20.21x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Bristol-Myers Squibb Company (BMY)?

The interest coverage ratio for BMY stock is 7.26x.

Is Bristol-Myers Squibb Company's interest coverage ratio high or low?

The interest coverage ratio of 7.26x is in line with its 5-year average of 6.74x, around the middle of its 5-year range (3.61x–10.04x).

What is the TTM average interest coverage ratio for Bristol-Myers Squibb Company (BMY)?

The TTM average interest coverage ratio for BMY stock is 8.02x.

What is the 3Y average interest coverage ratio for Bristol-Myers Squibb Company (BMY)?

The 3Y average interest coverage ratio for BMY stock is 6.61x.

What is the 5Y average interest coverage ratio for Bristol-Myers Squibb Company (BMY)?

The 5Y average interest coverage ratio for BMY stock is 6.74x.

What is the 10Y average interest coverage ratio for Bristol-Myers Squibb Company (BMY)?

The 10Y average interest coverage ratio for BMY stock is 12.95x.

What is the 15Y average interest coverage ratio for Bristol-Myers Squibb Company (BMY)?

The 15Y average interest coverage ratio for BMY stock is 14.29x.

What is the 20Y average interest coverage ratio for Bristol-Myers Squibb Company (BMY)?

The 20Y average interest coverage ratio for BMY stock is 17.44x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	10.04x
2026-03-31	8.19x
2025-12-31	6.51x
2025-09-30	7.58x
2025-06-30	7.78x
2025-03-31	7.08x
2024-12-31	5.10x
2024-09-30	4.53x
2024-06-30	4.96x
2024-03-31	3.61x
2023-12-31	6.18x
2023-09-30	7.51x
2023-06-30	6.89x
2023-03-31	8.52x
2022-12-31	5.83x
2022-09-30	7.46x
2022-06-30	8.59x
2022-03-31	8.32x
2021-12-31	6.92x
2021-09-30	5.28x
2021-06-30	4.72x
2021-03-31	6.22x
2020-12-31	2.06x
2020-09-30	3.95x
2020-06-30	2.63x
2020-03-31	2.56x
2019-12-31	2.51x
2019-09-30	8.62x
2019-06-30	16.41x
2019-03-31	39.62x
2018-12-31	33.13x
2018-09-30	38.11x
2018-06-30	12.42x
2018-03-31	30.28x
2017-12-31	20.18x
2017-09-30	22.17x
2017-06-30	28.88x
2017-03-31	35.89x
2016-12-31	24.93x
2016-09-30	31.79x
2016-06-30	27.05x
2016-03-31	25.88x
2015-12-31	-3.05x
2015-09-30	15.02x
2015-06-30	2.51x
2015-03-31	22.00x
2014-12-31	-0.02x
2014-09-30	14.06x
2014-06-30	6.50x
2014-03-31	13.20x
2013-12-31	16.26x
2013-09-30	17.09x
2013-06-30	12.56x
2013-03-31	13.10x
2012-12-31	10.22x
2012-09-30	11.60x
2012-06-30	24.59x
2012-03-31	43.88x
2011-12-31	37.57x
2011-09-30	43.52x
2011-06-30	54.28x
2011-03-31	51.32x
2010-12-31	27.02x
2010-09-30	41.34x
2010-06-30	47.25x
2010-03-31	44.82x
2009-09-30	30.68x
2009-06-30	32.88x
2009-03-31	19.15x
2008-03-31	14.88x

DATE

INTEREST COVERAGE RATIO

2026-06-30

10.04x

2026-03-31

8.19x

2025-12-31

6.51x

2025-09-30

7.58x

2025-06-30

7.78x

2025-03-31

7.08x

2024-12-31

5.10x

2024-09-30

4.53x

2024-06-30

4.96x

2024-03-31

3.61x

2023-12-31

6.18x

2023-09-30

7.51x

2023-06-30

6.89x

2023-03-31

8.52x

2022-12-31

5.83x

2022-09-30

7.46x

2022-06-30

8.59x

2022-03-31

8.32x

2021-12-31

6.92x

2021-09-30

5.28x

2021-06-30

4.72x

2021-03-31

6.22x

2020-12-31

2.06x

2020-09-30

3.95x

2020-06-30

2.63x

2020-03-31

2.56x

2019-12-31

2.51x

2019-09-30

8.62x

2019-06-30

16.41x

2019-03-31

39.62x

2018-12-31

33.13x

2018-09-30

38.11x

2018-06-30

12.42x

2018-03-31

30.28x

2017-12-31

20.18x

2017-09-30

22.17x

2017-06-30

28.88x

2017-03-31

35.89x

2016-12-31

24.93x

2016-09-30

31.79x

2016-06-30

27.05x

2016-03-31

25.88x

2015-12-31

-3.05x

2015-09-30

15.02x

2015-06-30

2.51x

2015-03-31

22.00x

2014-12-31

-0.02x

2014-09-30

14.06x

2014-06-30

6.50x

2014-03-31

13.20x

2013-12-31

16.26x

2013-09-30

17.09x

2013-06-30

12.56x

2013-03-31

13.10x

2012-12-31

10.22x

2012-09-30

11.60x

2012-06-30

24.59x

2012-03-31

43.88x

2011-12-31

37.57x

2011-09-30

43.52x

2011-06-30

54.28x

2011-03-31

51.32x

2010-12-31

27.02x

2010-09-30

41.34x

2010-06-30

47.25x

2010-03-31

44.82x

2009-09-30

30.68x

2009-06-30

32.88x

2009-03-31

19.15x

2008-03-31

14.88x

Interest Coverage Ratio: 7.26x

BMY Interest Coverage Ratio

BMY Average Interest Coverage Ratio Chart

BMY Current vs Average Interest Coverage Ratio Chart

BMY Interest Coverage Ratio Metrics

BMY Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

BMY Interest Coverage Ratio History

Related Metrics